These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 19474297)
81. Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome. Davis RO; Cosper P; Huddleston JF; Bradley EL; Finley SC; Finley WH; Milunsky A Am J Obstet Gynecol; 1985 Nov; 153(5):541-4. PubMed ID: 2414991 [TBL] [Abstract][Full Text] [Related]
82. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. Cho CK; Smith CR; Diamandis EP J Proteome Res; 2010 Jul; 9(7):3574-82. PubMed ID: 20459121 [TBL] [Abstract][Full Text] [Related]
83. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome. Witkin SS; Vardhana S; Yih M; Doh K; Bongiovanni AM; Gerber S Am J Obstet Gynecol; 2003 Nov; 189(5):1413-7. PubMed ID: 14634579 [TBL] [Abstract][Full Text] [Related]
84. Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension. Galambos C; Minic AD; Bush D; Nguyen D; Dodson B; Seedorf G; Abman SH PLoS One; 2016; 11(8):e0159005. PubMed ID: 27487163 [TBL] [Abstract][Full Text] [Related]
85. Second-trimester IL-15 and IL-18 levels in the amniotic fluid of fetuses with normal karyotypes and with chromosome abnormalities. Klimkiewicz-Blok D; Florjański J; Zalewski J; Blok R Adv Clin Exp Med; 2012; 21(2):201-5. PubMed ID: 23214284 [TBL] [Abstract][Full Text] [Related]
86. Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down syndrome: dysregulation of T-complex protein 1. Yoo BC; Fountoulakis M; Dierssen M; Lubec G J Neural Transm Suppl; 2001; (61):321-34. PubMed ID: 11771755 [TBL] [Abstract][Full Text] [Related]
87. [Screening and identification of human chromosome 21 genes resulting in abnormal development of fetal cerebral cortex with Down syndrome]. Yu WD; Liang R; Yang LJ; Shang M; Shen H; Guan J; Guo JZ Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2759-63. PubMed ID: 18167266 [TBL] [Abstract][Full Text] [Related]
88. Ultrasonographic femur-tibial length ratio: a marker of Down syndrome from the late second trimester. Gupta R; Thomas RD; Sreenivas V; Walter S; Puliyel JM Am J Perinatol; 2001 Jun; 18(4):217-24. PubMed ID: 11444366 [TBL] [Abstract][Full Text] [Related]
89. [The transfer of drugs into the amniotic fluid]. Amon I; Amon K Zentralbl Gynakol; 1976; 98(16):961-9. PubMed ID: 9756 [TBL] [Abstract][Full Text] [Related]
90. Transport of steroids between fetuses via amniotic fluid in relation to the intrauterine position phenomenon in rats. Even MD; Dhar MG; vom Saal FS J Reprod Fertil; 1992 Nov; 96(2):709-16. PubMed ID: 1339850 [TBL] [Abstract][Full Text] [Related]
91. Effects of intrauterine growth restriction and intraamniotic insulin-like growth factor-I treatment on blood and amniotic fluid concentrations and on fetal gut uptake of amino acids in late-gestation ovine fetuses. Bloomfield FH; van Zijl PL; Bauer MK; Harding JE J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):287-97. PubMed ID: 12352515 [TBL] [Abstract][Full Text] [Related]
92. Low levels of amniotic fluid pregnancy specific beta-1-glycoprotein in Down's syndrome. Kelly AJ; Wathen NC; Rice A; Iles RK; Ind TE; Chard T Early Hum Dev; 1994 Jun; 37(3):175-8. PubMed ID: 7925075 [TBL] [Abstract][Full Text] [Related]
93. Overexpression of transcription factor BACH1 in fetal Down syndrome brain. Ferrando-Miguel R; Cheon MS; Yang JW; Lubec G J Neural Transm Suppl; 2003; (67):193-205. PubMed ID: 15068251 [TBL] [Abstract][Full Text] [Related]
94. Amniotic fluid alpha-fetoprotein levels and fetal chromosomal abnormalities. Barkai G; Katznelson MB; Chaki R; Reichman B; Modan M; Meir E; Serr DM; Goldman B Gynecol Obstet Invest; 1987; 24(3):155-60. PubMed ID: 2446968 [TBL] [Abstract][Full Text] [Related]
96. Pre-pregnancy BMI, gestational weight gain, and telomere length in amniotic fluid: a causal graph analysis. Barchitta M; Maugeri A; La Mastra C; Favara G; La Rosa MC; Magnano San Lio R; Gholizade Atani Y; Gallo G; Agodi A Sci Rep; 2024 Oct; 14(1):23396. PubMed ID: 39379607 [TBL] [Abstract][Full Text] [Related]
97. Gene Expression Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes? Chapman LR; Ramnarine IVP; Zemke D; Majid A; Bell SM Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474215 [TBL] [Abstract][Full Text] [Related]
98. Maternal and Fetal Factors Affecting Cell-Free Fetal DNA (cffDNA) Fraction: A Systematic Review. Zaki-Dizaji M; Shafiee A; Kohandel Gargari O; Fathi H; Heidary Z J Reprod Infertil; 2023; 24(4):219-231. PubMed ID: 38164433 [TBL] [Abstract][Full Text] [Related]
99. Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease. García O; Flores-Aguilar L Front Cell Neurosci; 2022; 16():987212. PubMed ID: 36212691 [TBL] [Abstract][Full Text] [Related]
100. Emerging technologies for prenatal diagnosis: The application of whole genome and RNA sequencing. Liu P; Vossaert L Prenat Diagn; 2022 May; 42(6):686-696. PubMed ID: 35416301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]